Rhode’s Surge Masks e.l.f.’s Core Weakness and Stretched Valuation

What happened

e.l.f. Beauty’s stock is rallying as the Rhode brand delivers impressive growth, fueling optimism that the acquisition is paying off. However, this surge obscures the fact that the company’s core organic growth, excluding Rhode, is running at only 3–4%, while adjusted net income is actually guided lower for FY26. Gross margins remain under pressure from elevated China tariffs, and marketing spend is eating into profitability. The stock still trades at 64x trailing earnings and 28x EV/EBITDA, embedding expectations for a rapid return to mid-teens organic growth that looks increasingly unlikely. Without a material reacceleration in the base business, the current rally likely represents a selling opportunity rather than a sustainable re-rating.

Implication

Investors should recognize that Rhode is a bright spot, but it is not yet large enough to offset stagnation in the legacy portfolio and margin compression from tariffs. The thesis remains cautious: unless organic ex-Rhode growth moves decisively above 5% and gross margins recover toward 70%, the stock is likely to face further multiple compression. A more attractive entry point emerges around $65, where a base-case scenario of 5–7% organic growth and 20–21% EBITDA margins would offer a better risk-reward. Until then, patience is warranted, and any position should be sized for volatility and potential downside.

Thesis delta

Rhode’s strong early performance adds a layer of near-term narrative support, but it does not alter the core concern: e.l.f.’s legacy business is growing slowly, earnings are declining, and valuation remains historically high despite a 40% drawdown. The fundamental risk that the market is overpaying for an acquisition-fueled growth story remains intact, so the sell rating holds.